NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Partners with Tekkfund Capital, Issues Shares for Services
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, has entered into an agreement with Tekkfund Capital Corp. According to the contract, Tekkfund will help structure and assist with FSD Pharma business development strategies. In return, FSD Pharma has agreed to pay a C$12,500 monthly fee as well as issue 7,000 Class B subordinate voting shares every month to Tekkfund for the duration of the agreement, which is for 24 months initially but allows for an extension. According to the announcement, those shares will be subject to…







